Delivery Order SPE2DB22D1106-SPE2DB25FDTL4

Award Date 1/7/25
Potential Completion Date 1/8/25
Potential Value $12K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of 4558972905 GANIRELIX ACET 250 MCG/0.5 ML 0.5ML. The contract, valued at $3,388.08, is a firm fixed price delivery order with a completion date of November 3, 2022. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This...
This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the delivery of GANIRELIX ACET 250 MCG/0.5 ML 0.5ML pharmaceutical products. The $14,602.49 firm fixed-price delivery order was awarded by the Defense Logistics Agency (DLA), a defense agency that provides logistics, acquisition, and technical services to the U.S. Armed Forces and other government agencies. Amerisourcebergen, a major pharmaceutical distributor, holds two Indefinite Delivery Contracts...
This federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical was issued to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $7,506.80 firm fixed-price delivery order is for the supply of 4,566,559,881 units of the drug Ganirelix Acetate 250 mcg/0.5 mL. The contract has an ultimate completion date of November 29, 2024. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop...
The U.S. Defense Logistics Agency (DLA) Troop Support Medical awarded a $20,718.28 firm-fixed-price delivery order contract to AmerisourceBergen Drug Corp's Corporate Office division for the supply of 4,565,662,809 units of the pharmaceutical product Ganirelix Acetate 250 mcg/0.5 mL. This contract does not have a set-aside designation and has a completion date of September 4, 2024. AmerisourceBergen, a major pharmaceutical distributor, has been awarded numerous federal contracts and indefinite...
This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $20,746.69 firm fixed-price delivery order is for the supply of Ganirelix Acetate, a medication used in infertility treatments. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical to provide...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of 4,560,726,414 units of Ganirelix Acetate 250 mcg/0.5 mL injectable medication, with a ceiling value of $1,295.82 and a performance period ending on April 27, 2023. This contract is not set aside for any specific business categories. AmerisourceBergen holds a larger Indefinite...
The Defense Logistics Agency awarded a $6,975.00 firm fixed price delivery order to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide 4563265975 ! GANIRELIX ACET 250 MCG/0.5 ML 0.S ML. The delivery order is for pharmaceutical products to support Defense Logistics Agency Troop Support Medical programs and facilities. Amerisourcebergen Drug Corp, through its Corporate Office division, has a history of providing pharmaceuticals, medical supplies, and related...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $99,353.28 firm fixed-price delivery order is for the supply of GONAL-F RFF REDI-JECT 450 UNIT 0.75ML, a specialty pharmaceutical product. This award is a task order under Amerisourcebergen's $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which provides a...
This federal contract award is for the delivery of GONAL-F RFF REDI-JECT 900 UNIT 1.5ML medical products. The contract was awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, in the amount of $32,854.08. The contract is a Firm Fixed Price Delivery Order with a completion date of May 17, 2023. This award is associated with a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and the...
This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $43,020.80, is for the delivery of GONAL-F RFF REDI-JECT 900 unit 1.5ML medical products. It is a firm-fixed-price delivery order contract with a completion date of December 31, 2024. The contract is not designated as a set-aside. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery...
  • SPE2DB22D1106
    Indefinite Delivery Contract
  • SPE2DB22D1106-SPE2DB25FDTL4
    Delivery Order

This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $11,534.38 Firm Fixed Price Delivery Order covers the supply of GANIRELIX ACET 250 MCG/0.5 ML 0.0.5ML, a medical product, to support federal healthcare programs.

The award is associated with Amerisourcebergen's Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract does not have a set-aside designation, indicating open competition.

Generated 4/8/25, 9:51 AM